Search

everythinglearnresearchcommunity

for

Search:↓

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

EGFR inhibitors can cause unusual localized hair growth.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Tofacitinib may help treat hair loss in children with alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

M50054 may help treat hepatitis and hair loss from chemotherapy.

JAK inhibitors show promise for treating various skin diseases.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Ruxolitinib cream may help treat severe hair loss in children.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.